Recent Accomplishments

Making the CPI a stronger voice for researchers

The CPI has met repeatedly with top administration officials, such as President Henrich and Dean Hromas, as well as Dr. Giuffrida, the VP of Research to present their concerns  about topics of importance to researchers and the research enterprise. Through these meetings, the CPI has consistently ensured that research remains an important component of the Institution’s mission.

Plastic Waste and the Institution’s Recycling Program

The CPI recognized the growing problem of the waste generated by the extensive use of disposable plastic items by laboratories. A task force consisting of CPI members was formed to evaluate the waste and recycling program at the Institution and make recommendations to improve its effectiveness.

IT Issues

The CPI brought up issues with the transition to the new Outlook mail system with Mr. Yeman Collier of IMS, as well as the VPR Office, in particular the amount of spam email being received, concerns about the use of faculty contact information, and operational security, in order to address user complaints and effective operation of our computing and network systems.

Moderation of increased LAR per diem rates

CPI met with Dr. Giuffrida to address a change in animal per diem rates, which included a large increase for many species and strains including nude mice and rabbits, to further understand the rationale behind this sudden change and put forth faculty concerns.


Recent News

Study will compare treatment strategies for severe brain injury

A study of emergency care involving victims of severe brain trauma is to be performed in the San Antonio area.

Voelcker Fund awards $650,000 to cancer researchers on the rise

The Max and Minnie Tomerlin Voelcker Fund is awarding $650,000 to UT Health San Antonio to support innovative cancer research projects conducted by rising star faculty members.

Stroke bleeds in the brain not decreasing, study finds

Brain bleeds, called intracerebral hemorrhages, remained stable in incidence among all age groups over the past 30 years, but they increased in people 75 and older, according to a new analysis of the Framingham Heart Study. The findings were published June 8 in JAMA Neurology.

Researchers pinpoint a protein that may predict untreatable kidney cancer

A team of researchers confirmed the role of a certain protein in the development of high-grade kidney cancer. They also showed that a higher level of the protein can be used as a marker to predict which tumors will develop treatment resistance and progress more rapidly.

Risk of death twice as high among cancer patients with COVID-19

Mays Cancer Center faculty members authored the data analysis involving more than 900 cancer patients.

Cancer drugs cause large cells that resist treatment; scientist aims to stop it

Fueled by genetic changes due to cancer therapy itself, rogue cells may become very large with twice or quadruple the number of chromosomes found in healthy cells.  Dr. Daruka Mahadevan, of the Mays Cancer Center, seeks to find drugs that prevent or treat this problem.

More News